α-TEA cooperates with MEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways

被引：0
|
作者：
R Tiwary
W Yu
B G Sanders
K Kline
机构：
[1] School of Biological Sciences/C0900,Department of Nutritional Sciences/A2703
[2] University of Texas,undefined
[3] 1 University Station,undefined
[4] University of Texas,undefined
[5] 1 University Station,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
-TEA; Akt; breast cancer; ERK; IRS-1; mTOR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：101 / 109
页数：8
相关论文
共 50 条
  • [1] α-TEA cooperates with MEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways
    Tiwary, R.
    Yu, W.
    Sanders, B. G.
    Kline, K.
    BRITISH JOURNAL OF CANCER, 2011, 104 (01) : 101 - 109
  • [2] Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
    Qingfang Li
    Zhihui Li
    Ting Luo
    Huashan Shi
    Molecular Biomedicine, 3
  • [3] Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
    Li, Qingfang
    Li, Zhihui
    Luo, Ting
    Shi, Huashan
    MOLECULAR BIOMEDICINE, 2022, 3 (01):
  • [4] Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
    Saini, Kamal S.
    Loi, Sherene
    de Azambuja, Evandro
    Metzger-Filho, Otto
    Saini, Monika Lamba
    Ignatiadis, Michail
    Dancey, Janet E.
    Piccart-Gebhart, Martine J.
    CANCER TREATMENT REVIEWS, 2013, 39 (08) : 935 - 946
  • [5] mTOR kinase inhibitor potentiates apoptosis of PI3K and MEK inhibitors in diagnostically defined subpopulations
    Vijapurkar, Ulka
    Robillard, Liliane
    Zhou, Siqun
    Degtyarev, Michael
    Lin, Kui
    Truong, Tom
    Tremayne, Jarrod
    Ross, Leanne Berry
    Pei, Zhonghua
    Friedman, Lori S.
    Blackwood, Elizabeth M.
    Belvin, Marcia
    CANCER LETTERS, 2012, 326 (02) : 168 - 175
  • [6] Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways
    Dong, Pingping
    Hao, Fengmei
    Dai, Shufeng
    Tian, Lin
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2018, 38 (01) : 83 - 88
  • [7] NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells
    Liu, Ling
    Chen, Jingjing
    Cao, Mengyao
    Wang, Jiangang
    Wang, Shuying
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (06) : 1303 - 1314
  • [8] Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy
    Chang, Raymond
    Tosi, Umberto
    Voronina, Julia
    Adeuyan, Oluwaseyi
    Wu, Linda Y.
    Schweitzer, Melanie E.
    Pisapia, David J.
    Becher, Oren J.
    Souweidane, Mark M.
    Maachani, Uday B.
    NEURO-ONCOLOGY ADVANCES, 2019, 1 (01)
  • [9] The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition
    E J Haagensen
    S Kyle
    G S Beale
    R J Maxwell
    D R Newell
    British Journal of Cancer, 2012, 106 : 1386 - 1394
  • [10] The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition
    Haagensen, E. J.
    Kyle, S.
    Beale, G. S.
    Maxwell, R. J.
    Newell, D. R.
    BRITISH JOURNAL OF CANCER, 2012, 106 (08) : 1386 - 1394
12345